Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Luca Prosperini & Simona Pontecorvo. (2016) Dimethyl fumarate in the management of multiple sclerosis: appropriate patient selection and special considerations. Therapeutics and Clinical Risk Management 12, pages 339-350.
Read now
Read now
A Scott Nielsen. (2015) Advances in the management of relapsing–remitting multiple sclerosis: role of oral dimethyl fumarate (BG-12). Degenerative Neurological and Neuromuscular Disease 5, pages 51-61.
Read now
Read now
Nourollah Ramroodi, Masood Khani, Zohre Ganjali, Mohammad Reza Javan, Nima Sanadgol, Roghayeh Khalseh, Hadi Ravan, Ehsan Sanadgol & Mohammad Abdollahi. (2015) Prophylactic Effect of BIO-1211 Small-Molecule Antagonist of VLA-4 in the EAE Mouse Model of Multiple Sclerosis. Immunological Investigations 44:7, pages 694-712.
Read now
Read now
Kate Rittenhouse-Olson. (2013) Letter from the Editor. Immunological Investigations 42:7, pages 505-509.
Read now
Read now
Articles from other publishers (16)
Federico Manai, Stefano Govoni & Marialaura Amadio. (2022) The Challenge of Dimethyl Fumarate Repurposing in Eye Pathologies. Cells 11:24, pages 4061.
Crossref
Crossref
J. Sulaimani, D. Cluxton, J. Clowry, A. Petrasca, O.E. Molloy, B. Moran, C.M. Sweeney, A. Malara, N. McNicholas, C. McGuigan, B. Kirby & J.M. Fletcher. (2020) Dimethyl fumarate modulates the Treg–Th17 cell axis in patients with psoriasis*. British Journal of Dermatology 184:3, pages 495-503.
Crossref
Crossref
Maryam Zarrabi, Mohammadali Nazarinia, Abbas Rahimi Jaberi, Nasser Gholijani & Zahra Amirghofran. (2021) Elevated IL-38 Serum Levels in Newly Diagnosed Multiple Sclerosis and Systemic Sclerosis Patients. Medical Principles and Practice 30:2, pages 146-153.
Crossref
Crossref
Sotaro Mori, Takuji Kurimoto, Hidetaka Maeda & Makoto Nakamura. (2020) Dimethyl Fumarate Promotes the Survival of Retinal Ganglion Cells after Optic Nerve Injury, Possibly through the Nrf2/HO-1 Pathway. International Journal of Molecular Sciences 22:1, pages 297.
Crossref
Crossref
Marcello Moccia, Antonio Capacchione, Roberta Lanzillo, Fortunata Carbone, Teresa Micillo, Francesco Perna, Anna De Rosa, Antonio Carotenuto, Roberto Albero, Giuseppe Matarese, Raffaele Palladino & Vincenzo Brescia Morra. (2019) Coenzyme Q10 supplementation reduces peripheral oxidative stress and inflammation in interferon-β1a-treated multiple sclerosis. Therapeutic Advances in Neurological Disorders 12, pages 175628641881907.
Crossref
Crossref
Matthew Cummings, Anitha Christy Sigamani Arumanayagam, Picheng Zhao, Sunil Kannanganat, Olaf Stuve, Nitin J. Karandikar & Todd N. Eagar. (2018) Presenilin1 regulates Th1 and Th17 effector responses but is not required for experimental autoimmune encephalomyelitis. PLOS ONE 13:8, pages e0200752.
Crossref
Crossref
Jürgen Brück, Ralf Dringen, Adriana Amasuno, Ignasi Pau-Charles & Kamran Ghoreschi. (2018) A review of the mechanisms of action of dimethylfumarate in the treatment of psoriasis. Experimental Dermatology 27:6, pages 611-624.
Crossref
Crossref
Cristiana Pistono, Cecilia Osera, Chiara Boiocchi, Giulia Mallucci, Mariaclara Cuccia, Roberto Bergamaschi & Alessia Pascale. (2017) What’s new about oral treatments in Multiple Sclerosis? Immunogenetics still under question. Pharmacological Research 120, pages 279-293.
Crossref
Crossref
Jamie L. Lim, Susanne M.A. van der Pol, Flaminia Di Dio, Bert van het Hof, Gijs Kooij, Helga E. de Vries & Jack van Horssen. (2016) Protective effects of monomethyl fumarate at the inflamed blood–brain barrier. Microvascular Research 105, pages 61-69.
Crossref
Crossref
Catharina C. GrossAndreas Schulte-MecklenbeckSvenja KlinsingAnita Posevitz-FejfárHeinz WiendlLuisa Klotz. (2016) Dimethyl fumarate treatment alters circulating T helper cell subsets in multiple sclerosis. Neurology Neuroimmunology & Neuroinflammation 3:1.
Crossref
Crossref
E. V. Popova, A. N. Boyko & E. V. Orlova. (2016) Dimethylfumarate in the treatment of relapsing-remitting multiple sclerosis. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 116:10. Vyp. 2, pages 68.
Crossref
Crossref
A. Salmen, R.A. Linker & R. Gold. 2016. Translational Neuroimmunology in Multiple Sclerosis. Translational Neuroimmunology in Multiple Sclerosis
271
283
.
Calliope A. Dendrou, Lars Fugger & Manuel A. Friese. (2015) Immunopathology of multiple sclerosis. Nature Reviews Immunology 15:9, pages 545-558.
Crossref
Crossref
Sahar Tahvili, Basira Zandieh & Zahra Amirghofran. (2015) The effect of dimethyl fumarate on gene expression and the level of cytokines related to different T?helper cell subsets in peripheral blood mononuclear cells of patients with psoriasis. International Journal of Dermatology 54:7, pages e254-e260.
Crossref
Crossref
Anke Salmen & Ralf Gold. (2014) Mode of action and clinical studies with fumarates in multiple sclerosis. Experimental Neurology 262, pages 52-56.
Crossref
Crossref
Martin Marziniak. (2014) Neue Therapieoptionen. MMW - Fortschritte der Medizin 156:23, pages 69-76.
Crossref
Crossref